First Trust Advisors LP Amphastar Pharmaceuticals, Inc. Transaction History

First Trust Advisors LP

$127 Billion
Q3 2025

A detailed history of First Trust Advisors LP transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, First Trust Advisors LP holds 150,422 shares of AMPH stock, worth $3.92 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

150,422

Previous 94,305 59.51%

Holding current value

$3.92 Million

Previous $2.17 Million 85.13%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	BUY	$20.62 - $30.81 $1.16 Million - $1.73 Million	56,117 Added 59.51%	150,422 $4.01 Million
Q2 2025 Aug 13, 2025	BUY	$22.96 - $28.29 $1.76 Million - $2.16 Million	76,453 Added 428.26%	94,305 $2.17 Million
Q1 2025 May 14, 2025	SELL	$26.24 - $38.48 $1.66 Million - $2.43 Million	-63,277 Reduced 78.0%	17,852 $517,000
Q4 2024 Feb 13, 2025	BUY	$36.84 - $53.4 $2.32 Million - $3.37 Million	63,100 Added 349.99%	81,129 $3.01 Million
Q3 2024 Nov 13, 2024	BUY	$36.99 - $50.09 $307,719 - $416,698	8,319 Added 85.67%	18,029 $874,000

Q2 2024 Aug 13, 2024	SELL	$38.65 - $43.48 $2.22 Million - $2.49 Million	-57,376 Reduced 85.53%	9,710 $388,000
Q1 2024 May 13, 2024	BUY	$42.85 - $63.45 $864,241 - $1.28 Million	20,169 Added 42.99%	67,086 $2.95 Million
Q4 2023 Feb 13, 2024	SELL	$44.49 - $62.93 $1.43 Million - $2.02 Million	-32,146 Reduced 40.66%	46,917 $2.9 Million
Q3 2023 Nov 13, 2023	SELL	$45.51 - $65.0 $1.04 Million - $1.49 Million	-22,874 Reduced 22.44%	79,063 $3.64 Million
Q2 2023 Aug 14, 2023	BUY	$35.77 - $58.38 $2.2 Million - $3.6 Million	61,604 Added 152.74%	101,937 $5.86 Million
Q1 2023 May 15, 2023	SELL	$27.99 - $37.92 $690,121 - $934,955	-24,656 Reduced 37.94%	40,333 $1.51 Million
Q4 2022 Feb 09, 2023	BUY	$27.93 - $31.27 $1.82 Million - $2.03 Million	64,989 New	64,989 $1.82 Million
Q2 2021 Aug 16, 2021	SELL	$17.11 - $20.92 $537,527 - $657,222	-31,416 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$17.21 - $20.65 $56,741 - $68,083	-3,297 Reduced 9.5%	31,416 $584,000
Q4 2020 Feb 02, 2021	BUY	$17.76 - $21.24 $616,502 - $737,304	34,713 New	34,713 $698,000
Q2 2020 Jul 22, 2020	SELL	$14.25 - $22.46 $608,460 - $959,019	-42,699 Closed	0 $0
Q1 2020 May 06, 2020	SELL	$12.66 - $20.08 $733,115 - $1.16 Million	-57,908 Reduced 57.56%	42,699 $634,000
Q4 2019 Feb 03, 2020	SELL	$17.07 - $20.64 $408,126 - $493,481	-23,909 Reduced 19.2%	100,607 $1.94 Million
Q3 2019 Nov 04, 2019	BUY	$19.12 - $22.62 $170,971 - $202,268	8,942 Added 7.74%	124,516 $2.47 Million
Q2 2019 Jul 30, 2019	BUY	$18.92 - $22.96 $2.19 Million - $2.65 Million	115,574 New	115,574 $2.44 Million

Others Institutions Holding AMPH

# of Institutions

262

Shares Held

33.5M

Call Options Held

73.4K

Put Options Held

12.6K

View Full List

About Amphastar Pharmaceuticals, Inc.

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.28B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

More about AMPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Account

First Trust Advisors LP Amphastar Pharmaceuticals, Inc. Transaction History